Precision epileptology: digital biomarkers and cognitive proxies for personalized care

Abstract

AbstractThe widespread accessibility of smart devices, even if not designated as medical devices, coupled with the critical need for ongoing monitoring of patients taking anti-seizure medication or undergoing new stimulation therapies highlights the urgent need for collaborative research across disciplines. These therapies, while beneficial, may cause sporadic or temporally dynamic side effects affecting cognition and behavior that cannot be adequately assessed by traditional neuropsychological testing methods at certain time points. This scenario highlights the importance of developing innovative approaches to fully monitor and understand these dynamic effects.